Differential utilization of ketone bodies by neurons and glioma cell lines: A rationale for ketogenic diet as experimental glioma therapy

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Maurer, Gabriele D ^a   Brucker, Daniel P ^a   Bähr, Oliver ^a   Harter, Patrick N ^a   Hattingen, Elke ^a   Walenta, Stefan ^b   Mueller Klieser, Wolfgang ^b   Steinbach, Joachim P ^a   Rieger, Johannes ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRATE DEHYDROGENASE; 3 HYDROXYBUTYRATE DEHYDROGENASE 1; 3 HYDROXYBUTYRATE DEHYDROGENASE 2; 3 HYDROXYBUTYRIC ACID; 3 OXOACID COENZYME A TRANSFERASE; 3 OXOACID COENZYME A TRANSFERASE 1; ACETYL COENZYME A ACYLTRANSFERASE; ACETYL COENZYME A ACYLTRANSFERASE 1; GLUCOSE; KETONE BODY; MESSENGER RNA; SUCCINIC ACID; UNCLASSIFIED DRUG; 3-KETOACID COA-TRANSFERASE; ACAT1 PROTEIN, HUMAN; ACETYL COENZYME A ACETYLTRANSFERASE; COENZYME A TRANSFERASE; HYDROXYBUTYRATE DEHYDROGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BRAIN NERVE CELL; BRAIN REGION; CANCER GROWTH; CANCER INVASION; CANCER THERAPY; CELL DENSITY; CELL HYPOXIA; CELL METABOLISM; CELL MOTILITY; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DIET RESTRICTION; DOWN REGULATION; ENERGY METABOLISM; ENZYME METABOLISM; FEMALE; GLIOMA; GLIOMA CELL; GLUCOSE BLOOD LEVEL; HIPPOCAMPUS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KETOGENIC DIET; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; SURVIVAL RATE; SURVIVAL TIME; THERAPY EFFECT; TUMOR XENOGRAFT; ANIMAL; CELL CULTURE; CELL STRAIN 3T3; CELL SURVIVAL; CYTOLOGY; DIET THERAPY; DRUG EFFECT; DRUG SCREENING; GENETICS; IMMUNOBLOTTING; METABOLISM; NERVE CELL; NEWBORN; NUDE MOUSE; PATHOLOGY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WISTAR RAT;

3-HYDROXYBUTYRIC ACID; ACETYL-COA C-ACETYLTRANSFERASE; ANIMALS; ANIMALS, NEWBORN; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; COENZYME A-TRANSFERASES; FEMALE; GLIOMA; GLUCOSE; HUMANS; HYDROXYBUTYRATE DEHYDROGENASE; IMMUNOBLOTTING; KETOGENIC DIET; KETONE BODIES; MICE; MICE, NUDE; NEURONS; NIH 3T3 CELLS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79960661966     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-315     Document Type: Article

References (73)

1. Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, Burkhard C, Schuler D, Probst-Hensch NM, Maiorka PC, Baeza N, Pisani P, Yonekawa Y, Yasargil MG, Lutolf UM, Kleihues P. Genetic pathways to glioblastoma: a population-based study. Cancer Res 2004, 64:6892-6899. 10.1158/0008-5472.CAN-04-1337, 15466178.
2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352:987-996. 10.1056/NEJMoa043330, 15758009.
3. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314. 10.1126/science.123.3191.309, 13298683.
4. Harris AL. Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer 2002, 2:38-47. 10.1038/nrc704, 11902584.
5. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis?. Nat Rev Cancer 2004, 4:891-899. 10.1038/nrc1478, 15516961.
6. Morris AA. Cerebral ketone body metabolism. J Inherit Metab Dis 2005, 28:109-121. 10.1007/s10545-005-5518-0, 15877199.
7. Cahill GF, Veech RL. Ketoacids? Good medicine?. Trans Am Clin Climatol Assoc 2003, 114:149-161. discussion 162-143, 2194504, 12813917.
8. Bough KJ, Rho JM. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia 2007, 48:43-58.
9. Meixensberger J, Herting B, Roggendorf W, Reichmann H. Metabolic patterns in malignant gliomas. J Neurooncol 1995, 24:153-161. 10.1007/BF01078485, 7562002.
10. Oudard S, Boitier E, Miccoli L, Rousset S, Dutrillaux B, Poupon MF. Gliomas are driven by glycolysis: putative roles of hexokinase, oxidative phosphorylation and mitochondrial ultrastructure. Anticancer Res 1997, 17:1903-1911.
11. Kiebish MA, Han X, Cheng H, Seyfried TN. In vitro growth environment produces lipidomic and electron transport chain abnormalities in mitochondria from non-tumorigenic astrocytes and brain tumours. ASN Neuro 2009, 1.
12. Maalouf M, Rho JM, Mattson MP. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev 2009, 59:293-315. 10.1016/j.brainresrev.2008.09.002, 2649682, 18845187.
13. Prins ML. Cerebral metabolic adaptation and ketone metabolism after brain injury. J Cereb Blood Flow Metab 2008, 28:1-16. 10.1038/sj.jcbfm.9600543, 2857668, 17684514.
14. Tisdale MJ, Brennan RA. Loss of acetoacetate coenzyme A transferase activity in tumours of peripheral tissues. Br J Cancer 1983, 47:293-297. 10.1038/bjc.1983.38, 2011283, 6130780.
15. Fredericks M, Ramsey RB. 3-Oxo acid coenzyme A transferase activity in brain and tumors of the nervous system. J Neurochem 1978, 31:1529-1531. 10.1111/j.1471-4159.1978.tb06581.x, 298319.
16. Nebeling LC, Miraldi F, Shurin SB, Lerner E. Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports. J Am Coll Nutr 1995, 14:202-208.
17. Seyfried TN, Sanderson TM, El-Abbadi MM, McGowan R, Mukherjee P. Role of glucose and ketone bodies in the metabolic control of experimental brain cancer. Br J Cancer 2003, 89:1375-1382. 10.1038/sj.bjc.6601269, 2394295, 14520474.
18. Zhou W, Mukherjee P, Kiebish MA, Markis WT, Mantis JG, Seyfried TN. The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer. Nutr Metab (Lond) 2007, 4:5.
19. Rieger J, Baehr O, Hattingen E, Maurer G, Coy J, Weller M, Steinbach J. The ERGO trial: A pilot study of a ketogenic diet in patients with recurrent glioblastoma. J Clin Oncol (Meeting Abstracts) 2010, 28:e12532.
20. Richard DE, Berra E, Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 2000, 275:26765-26771.
21. Tian H, McKnight SL, Russell DW. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 1997, 11:72-82. 10.1101/gad.11.1.72, 9000051.
22. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992, 12:5447-5454. 360482, 1448077.
23. Wischhusen J, Naumann U, Ohgaki H, Rastinejad F, Weller M. CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death. Oncogene 2003, 22:8233-8245. 10.1038/sj.onc.1207198, 14614447.
24. Krohn AJ, Preis E, Prehn JH. Staurosporine-induced apoptosis of cultured rat hippocampal neurons involves caspase-1-like proteases as upstream initiators and increased production of superoxide as a main downstream effector. J Neurosci 1998, 18:8186-8197.
25. Hamprecht B, Loffler F. Primary glial cultures as a model for studying hormone action. Methods Enzymol 1985, 109:341-345.
26. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63. 10.1016/0022-1759(83)90303-4, 6606682.
27. Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc 2006, 1:2315-2319. 10.1038/nprot.2006.339, 17406473.
28. Ullah MS, Davies AJ, Halestrap AP. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J Biol Chem 2006, 281:9030-9037.
29. Dyer BW, Ferrer FA, Klinedinst DK, Rodriguez R. A noncommercial dual luciferase enzyme assay system for reporter gene analysis. Anal Biochem 2000, 282:158-161. 10.1006/abio.2000.4605, 10860516.
30. Albini A, Benelli R. The chemoinvasion assay: a method to assess tumor and endothelial cell invasion and its modulation. Nat Protoc 2007, 2:504-511. 10.1038/nprot.2006.466, 17406614.
31. Otto C, Kaemmerer U, Illert B, Muehling B, Pfetzer N, Wittig R, Voelker HU, Thiede A, Coy JF. Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides. BMC Cancer 2008, 8:122. 10.1186/1471-2407-8-122, 2408928, 18447912.
32. Walenta S, Schroeder T, Mueller-Klieser W. Metabolic mapping with bioluminescence: basic and clinical relevance. Biomol Eng 2002, 18:249-262. 10.1016/S1389-0344(01)00107-1, 11841946.
33. Mueller-Klieser W, Walenta S. Geographical mapping of metabolites in biological tissue with quantitative bioluminescence and single photon imaging. Histochem J 1993, 25:407-420. 10.1007/BF00157805, 7689547.
34. Webb JL. Effects of more than one inhibitor. Enzymes and metabolic inhibitors 1963, 1:487-512. New York: Academic Press, Webb JL.
35. Favaro E, Nardo G, Persano L, Masiero M, Moserle L, Zamarchi R, Rossi E, Esposito G, Plebani M, Sattler U, Mann T, Mueller-Klieser W, Ciminale V, Amadori A, Indraccolo S. Hypoxia inducible factor-1alpha inactivation unveils a link between tumor cell metabolism and hypoxia-induced cell death. Am J Pathol 2008, 173:1186-1201. 10.2353/ajpath.2008.071183, 2543085, 18772337.
36. Malhotra R, Brosius FC. Glucose uptake and glycolysis reduce hypoxia-induced apoptosis in cultured neonatal rat cardiac myocytes. J Biol Chem 1999, 274:12567-12575. 10.1074/jbc.274.18.12567, 10212235.
37. Steinbach JP, Wolburg H, Klumpp A, Probst H, Weller M. Hypoxia-induced cell death in human malignant glioma cells: energy deprivation promotes decoupling of mitochondrial cytochrome c release from caspase processing and necrotic cell death. Cell Death Differ 2003, 10:823-832. 10.1038/sj.cdd.4401252, 12815465.
38. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F, Hwang PM. p53 regulates mitochondrial respiration. Science 2006, 312:1650-1653. 10.1126/science.1126863, 16728594.
39. Beppu T, Kamada K, Yoshida Y, Arai H, Ogasawara K, Ogawa A. Change of oxygen pressure in glioblastoma tissue under various conditions. J Neurooncol 2002, 58:47-52. 10.1023/A:1015832726054, 12160140.
40. Cerniglia GJ, Wilson DF, Pawlowski M, Vinogradov S, Biaglow J. Intravascular oxygen distribution in subcutaneous 9L tumors and radiation sensitivity. J Appl Physiol 1997, 82:1939-1945.
41. Scigliano S, Pinel S, Poussier S, Fouyssac F, Plenat F, Karcher G, Chastagner P. Measurement of hypoxia using invasive oxygen-sensitive electrode, pimonidazole binding and 18F-FDG uptake in anaemic or erythropoietin-treated mice bearing human glioma xenografts. Int J Oncol 2008, 32:69-77.
42. Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, Pan Y, Simon MC, Thompson CB, Gottlieb E. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 2005, 7:77-85. 10.1016/j.ccr.2004.11.022, 15652751.
43. Roslin M, Henriksson R, Bergstrom P, Ungerstedt U, Bergenheim AT. Baseline levels of glucose metabolites, glutamate and glycerol in malignant glioma assessed by stereotactic microdialysis. J Neurooncol 2003, 61:151-160. 10.1023/A:1022106910017, 12622454.
44. Marcus HJ, Carpenter KL, Price SJ, Hutchinson PJ. In vivo assessment of high-grade glioma biochemistry using microdialysis: a study of energy-related molecules, growth factors and cytokines. J Neurooncol 2009, 97:11-23.
45. Tennant DA, Duran RV, Gottlieb E. Targeting metabolic transformation for cancer therapy. Nat Rev Cancer 2010, 10:267-277. 10.1038/nrc2817, 20300106.
46. Seyfried TN, Kiebish MA, Marsh J, Shelton LM, Huysentruyt LC, Mukherjee P. Metabolic management of brain cancer. Biochim Biophys Acta 2010,
47. Meredith D, Christian HC. The SLC16 monocaboxylate transporter family. Xenobiotica 2008, 38:1072-1106. 10.1080/00498250802010868, 18668440.
48. Tildon JT, McKenna MC, Stevenson JH. Transport of 3-hydroxybutyrate by cultured rat brain astrocytes. Neurochem Res 1994, 19:1237-1242. 10.1007/BF01006812, 7891839.
49. Page MA, Williamson DH. Enzymes of ketone-body utilisation in human brain. Lancet 1971, 2:66-68.
50. Samoilova M, Weisspapir M, Abdelmalik P, Velumian AA, Carlen PL. Chronic in vitro ketosis is neuroprotective but not anti-convulsant. J Neurochem 2010, 113:826-835. 10.1111/j.1471-4159.2010.06645.x, 20163521.
51. Nehlig A. Brain uptake and metabolism of ketone bodies in animal models. Prostaglandins Leukot Essent Fatty Acids 2004, 70:265-275. 10.1016/j.plefa.2003.07.006, 14769485.
52. DeVivo DC, Leckie MP, Ferrendelli JS, McDougal DB. Chronic ketosis and cerebral metabolism. Ann Neurol 1978, 3:331-337. 10.1002/ana.410030410, 666275.
53. Zhao Z, Lange DJ, Voustianiouk A, MacGrogan D, Ho L, Suh J, Humala N, Thiyagarajan M, Wang J, Pasinetti GM. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci 2006, 7:29. 10.1186/1471-2202-7-29, 1488864, 16584562.
54. Imamura K, Takeshima T, Kashiwaya Y, Nakaso K, Nakashima K. D-beta-hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease. J Neurosci Res 2006, 84:1376-1384. 10.1002/jnr.21021, 16917840.
55. Skinner R, Trujillo A, Ma X, Beierle EA. Ketone bodies inhibit the viability of human neuroblastoma cells. J Pediatr Surg 2009, 44:212-216. discussion 216, 10.1016/j.jpedsurg.2008.10.042, 19159745.
56. Puchowicz MA, Zechel JL, Valerio J, Emancipator DS, Xu K, Pundik S, LaManna JC, Lust WD. Neuroprotection in diet-induced ketotic rat brain after focal ischemia. J Cereb Blood Flow Metab 2008, 28:1907-1916. 10.1038/jcbfm.2008.79, 18648382.
57. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003, 3:721-732. 10.1038/nrc1187, 13130303.
58. Kaur B, Khwaja FW, Severson EA, Matheny SL, Brat DJ, Van Meir EG. Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro Oncol 2005, 7:134-153. 10.1215/S1152851704001115, 1871894, 15831232.
59. Bonuccelli G, Tsirigos A, Whitaker-Menezes D, Pavlides S, Pestell RG, Chiavarina B, Frank PG, Flomenberg N, Howell A, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle 2010, 9:3506-3514. 10.4161/cc.9.17.12731, 3047616, 20818174.
60. Froberg MK, Gerhart DZ, Enerson BE, Manivel C, Guzman-Paz M, Seacotte N, Drewes LR. Expression of monocarboxylate transporter MCT1 in normal and neoplastic human CNS tissues. Neuroreport 2001, 12:761-765. 10.1097/00001756-200103260-00030, 11277580.
61. Chechik T, Roeder LM, Tildon JT, Poduslo SE. Ketone body enzyme activities in purified neurons, astrocytes and oligodendroglia. Neurochem Int 1987, 10:95-99. 10.1016/0197-0186(87)90179-3, 20501089.
62. Edmond J, Robbins RA, Bergstrom JD, Cole RA, de Vellis J. Capacity for substrate utilization in oxidative metabolism by neurons, astrocytes, and oligodendrocytes from developing brain in primary culture. J Neurosci Res 1987, 18:551-561. 10.1002/jnr.490180407, 3481403.
63. Lopes-Cardozo M, Larsson OM, Schousboe A. Acetoacetate and glucose as lipid precursors and energy substrates in primary cultures of astrocytes and neurons from mouse cerebral cortex. J Neurochem 1986, 46:773-778. 10.1111/j.1471-4159.1986.tb13039.x, 3081684.
64. Levine AJ, Puzio-Kuter AM. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 2010, 330:1340-1344. 10.1126/science.1193494, 21127244.
65. DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S, Thompson CB. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA 2007, 104:19345-19350. 10.1073/pnas.0709747104, 2148292, 18032601.
66. Arismendi-Morillo GJ, Castellano-Ramirez AV. Ultrastructural mitochondrial pathology in human astrocytic tumors: potentials implications pro-therapeutics strategies. J Electron Microsc (Tokyo) 2008, 57:33-39.
67. Kirches E, Krause G, Warich-Kirches M, Weis S, Schneider T, Meyer-Puttlitz B, Mawrin C, Dietzmann K. High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples. Int J Cancer 2001, 93:534-538. 10.1002/ijc.1375, 11477557.
68. Michelakis ED, Sutendra G, Dromparis P, Webster L, Haromy A, Niven E, Maguire C, Gammer TL, Mackey JR, Fulton D, Abdulkarim B, McMurtry MS, Petruk KC. Metabolic modulation of glioblastoma with dichloroacetate. Sci Transl Med 2010, 2:31ra34.
69. Freedland SJ, Mavropoulos J, Wang A, Darshan M, Demark-Wahnefried W, Aronson WJ, Cohen P, Hwang D, Peterson B, Fields T, Pizzo SV, Isaacs WB. Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. Prostate 2008, 68:11-19. 10.1002/pros.20683, 17999389.
70. Spulber G, Spulber S, Hagenas L, Amark P, Dahlin M. Growth dependence on insulin-like growth factor-1 during the ketogenic diet. Epilepsia 2009, 50:297-303. 10.1111/j.1528-1167.2008.01769.x, 18727678.
71. Stafford P, Abdelwahab MG, Kim do Y, Preul MC, Rho JM, Scheck AC. The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma. Nutr Metab (Lond) 2010, 7:74.
72. Newcomb EW, Zagzag D. The murine GL261 glioma experimental model to assess novel brain tumor treatments. CNS cancer: models, markers, prognostic factors, targets, and therapeutic approaches 2009, 227-242. New York: Springer, Van Meir EG.
73. Keunen O, Johansson M, Oudin A, Sanzey M, Rahim SA, Fack F, Thorsen F, Taxt T, Bartos M, Jirik R, Miletic H, Wang J, Stieber D, Stuhr L, Moen I, Rygh CB, Bjerkvig R, Niclou SP. Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proc Natl Acad Sci USA 2011, 108:3749-3754. 10.1073/pnas.1014480108, 3048093, 21321221.